Viracta Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VIRX and other ETFs, options, and stocks.

About VIRX

Viracta Therapeutics, Inc. a clinical-stage, biomarker-directed precision oncology company focused on new medicines for the treatment of virus-associated malignancies. It develops antiviral agent valganciclovir as an oral combination therapy which is in a Phase 2 clinical trial for EBV-positive lymphomas. 

CEO
Mark A. Rothera
CEOMark A. Rothera
Employees
40
Employees40
Headquarters
Cardiff, California
HeadquartersCardiff, California
Founded
1998
Founded1998
Employees
40
Employees40

VIRX Key Statistics

Market cap
31.43M
Market cap31.43M
Price-Earnings ratio
-0.61
Price-Earnings ratio-0.61
Dividend yield
—
Dividend yield—
Average volume
49.21K
Average volume49.21K
High today
$0.84
High today$0.84
Low today
$0.791
Low today$0.791
Open price
$0.80
Open price$0.80
Volume
37.81K
Volume37.81K
52 Week high
$2.38
52 Week high$2.38
52 Week low
$0.43
52 Week low$0.43
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.